NYSE · Financial Statements

STERIS plc (STE) Revenue, Earnings & Financial Statements

$262.58 NYSE: STE Market Cap $25.50B

Data as of Nov 16, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

STERIS plc most recently reported annual revenue of $5.9B, net profit of $785.0M. Revenue grew at an average annual rate of 13.8% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

STERIS plc: Revenue rose from $2.6B in 2017 to $5.9B in 2026, a change of +127.2% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 8.7% to 18.6%, a shift of +9.9 percentage points; the most recent year shows net profit of $785.0M.

Income Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Revenue$2.6B$2.6B$2.8B$3.0B$3.1B$4.2B$4.5B$5.1B$5.5B$5.9B
Operating Expenses$2.4B$2.2B$2.4B$2.5B$2.6B$3.7B$3.7B$4.3B$4.6B$4.8B
Operating Profit$226.0M$400.0M$411.0M$537.0M$548.0M$478.0M$791.0M$836.0M$867.0M$1.1B
Operating Margin8.7%15.3%14.8%17.7%17.6%11.3%17.4%16.3%15.9%18.6%
Other Income−$42.0M−$45.0M−$42.0M−$38.0M−$31.0M−$111.0M−$111.0M−$133.0M−$70.0M−$54.0M
Interest$45.0M$51.0M$45.0M$40.0M$37.0M$89.0M$111.0M$144.0M$86.0M$61.0M
Depreciation$188.0M$178.0M$226.0M$197.0M$219.0M$553.0M$553.0M$565.0M$476.0M$487.0M
Profit Before Tax$185.0M$355.0M$369.0M$499.0M$518.0M$367.0M$680.0M$703.0M$796.0M$1.0B
Tax rate (%)40.1%17.9%17.4%18.2%23.3%22.4%18.2%21.3%23.2%25.0%
Net Profit$110.0M$291.0M$304.0M$408.0M$397.0M$244.0M$107.0M$378.0M$615.0M$785.0M
EPS$1.28$3.39$3.56$4.76$4.63$2.48$1.07$3.81$6.20$7.93

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$1.3B$1.1B$1.3B$1.3B$1.4B$1.5B$1.4B$1.5B$1.5B$1.6B$1.5B$1.6B
Operating Expenses$1.1B$871.0M$1.1B$1.1B$1.1B$1.3B$1.1B$1.2B$1.2B$1.3B$1.2B$1.3B
Operating Profit$226.0M$245.0M$186.0M$220.0M$245.0M$216.0M$246.0M$268.0M$271.0M$317.0M$286.0M$294.0M
Operating Margin17.4%22.0%14.5%16.5%17.9%14.6%17.7%18.4%18.1%19.9%19.1%18.5%
Interest$39.0M$36.0M$30.0M$20.0M$19.0M$17.0M$16.0M$15.0M$15.0M$15.0M$16.0M$11.0M
Profit Before Tax$190.0M$215.0M$175.0M$195.0M$229.0M$197.0M$232.0M$253.0M$258.0M$305.0M$274.0M$288.0M
Tax rate (%)21.6%20.1%20.1%22.3%24.2%25.6%23.2%23.9%24.6%27.6%26.5%25.7%
Net Profit$141.0M−$1.0M$145.0M$150.0M$174.0M$146.0M$177.0M$192.0M$193.0M$220.0M$200.0M$214.0M
EPS$1.42−$0.01$1.46$1.51$1.75$1.48$1.79$1.94$1.96$2.24$2.04$2.19

Over the 10 years reported for STERIS plc, borrowings increased from $1.5B in 2017 to $2.1B in 2026, cash stood at $440.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 2.09 times.

Balance Sheet — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Total Assets$4.9B$5.2B$5.1B$5.4B$6.6B$11.4B$10.8B$11.1B$10.1B$10.7B
Current Assets$1.0B$990.0M$1.1B$1.2B$1.2B$1.9B$2.0B$2.9B$2.0B$2.4B
Cash$283.0M$202.0M$221.0M$320.0M$221.0M$348.0M$208.0M$207.0M$172.0M$440.0M
Inventory$198.0M$206.0M$208.0M$264.0M$315.0M$575.0M$604.0M$675.0M$581.0M$632.0M
Receivables$483.0M$528.0M$565.0M$586.0M$609.0M$799.0M$865.0M$1.0B$1.0B$1.1B
Fixed Assets$916.0M$1.0B$1.0B$1.2B$1.4B$1.7B$1.8B$1.9B$2.1B$2.3B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$9.0M$8.0M$0$0$14.0M$0
Other Assets$2.2B$2.4B$2.3B$2.4B$3.0B$4.4B$3.9B$4.1B$4.1B$4.2B
Total Liabilities$2.1B$2.0B$1.9B$2.0B$2.7B$4.9B$4.7B$4.7B$3.5B$3.5B
Current Liabilities$382.0M$398.0M$465.0M$504.0M$578.0M$922.0M$862.0M$931.0M$1.0B$1.1B
Borrowings$1.5B$1.3B$1.2B$1.3B$1.8B$3.3B$3.2B$3.4B$2.2B$2.1B
Other Liabilities$636.0M$667.0M$704.0M$738.0M$880.0M$1.6B$1.5B$1.4B$1.3B$1.5B
Equity$2.1B$2.0B$2.0B$2.0B$2.0B$4.7B$4.5B$4.5B$4.4B$0
Reserves$2.8B$3.2B$3.2B$3.4B$3.9B$6.5B$6.1B$6.3B$6.6B$7.2B

For STERIS plc, operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $972.0M; free cash flow was positive in 10 of 10 years; financing activities used $237.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Operating Cash Flow$424.0M$458.0M$540.0M$591.0M$690.0M$685.0M$757.0M$973.0M$1.1B$1.3B
Investing Cash Flow−$277.0M−$369.0M−$409.0M−$534.0M−$1.4B−$954.0M−$745.0M−$1.2B$19.0M−$881.0M
Financing Cash Flow−$99.0M−$60.0M−$70.0M−$14.0M−$5.0M−$93.0M−$309.0M−$6.0M−$188.0M−$237.0M
Net Cash Flow$34.0M−$81.0M$19.0M$99.0M−$99.0M$128.0M−$140.0M−$1.0M−$35.0M$268.0M
Free Cash Flow$251.0M$292.0M$350.0M$376.0M$450.0M$397.0M$395.0M$613.0M$778.0M$972.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.45
EV / EBITDA17.18
FCF Yield3.76%
Quick Ratio1.44
Interest Coverage20.52
Return 1Y2.36%
Return 3Y32.20%
Return 5Y16.11%

STERIS plc (STE) financials — frequently asked questions

What is STERIS plc's annual revenue?

STERIS plc (STE) reported annual revenue of $5.9B in its most recent fiscal year.

What is STERIS plc's net profit?

STERIS plc (STE) reported net profit of $785.0M in its most recent fiscal year.

What is STE EV/EBITDA?

STERIS plc's enterprise value to EBITDA (EV/EBITDA) ratio is 17.18.

Revenue and earnings of other Medical - Specialties stocks

ALC revenue $10.4BMLAB revenue $249.0MQDEL revenue $2.7BMOBI stockSI stockMASS revenue $56.0MANIK revenue $113.0MAPYX revenue $53.0MSKIN revenue $301.0MNYXH revenue $10.0MAll Healthcare stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
STE Overview STE Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.